Abbott launches ‘OneLab’ software to manage lab data

Updated on 12 July 2012

Abbott’s new OneLab integrated informatics solution unites most of a lab's information and decision tools into one system

onelab-abbott-s-new-integrated-laboratory-informatics-software

OneLab: Abbott's new integrated laboratory informatics software

Singapore: Abbott has launched a web-based, integrated laboratory informatics solution called OneLab. It is a highly-configurable platform that allows labs of any size to standardize processes across multiple locations and automate routine procedures such as sample management and tracking, as well as test result review and approval.

OneLab's information management capability can improve efficiency and productivity while reducing errors, which is important for patient safety.

Mr Brian Blaser, executive VP, diagnostics products, Abbott, said that, "The essence of diagnostic testing is accurate medical information and, most importantly, the ability to provide it to clinicians when, where and how they need it. Our customers are processing large volumes of tests for physicians. OneLab allows labs to address these operational challenges without sacrificing quality or efficiency."

Informatics refers to the processing, management and retrieval of information, which is critical for making clinical decisions. In the laboratory, clinical decision-making requires access to timely and accurate information. OneLab unites most of a laboratory's information and decision tools into one easy-to-use system, allowing labs to manage data with a single user interface. The solution is comprised of three applications, including Smart Center, Inventory Manager, and Decision Center.

Abbott introduced OneLab in Australia, Belgium, France, Germany, Italy, Ireland, Luxembourg, The Netherlands, New Zealand, United Kingdom, and Spain. Additional launches, including the US, are scheduled for later in 2012 and 2013.

Leave a Reply

Notify me of follow-up comments via e-mail address

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X